Literature DB >> 25761937

Mechanisms of biofilm inhibition and degradation by antimicrobial peptides.

L Segev-Zarko1, Ron Saar-Dover1, Vlad Brumfeld2, Maria Luisa Mangoni3, Yechiel Shai1.   

Abstract

Many bacteria live as biofilms to cope with unfavourable surroundings. Biofilms start from (i) a planktonic stage, (ii) initial adhesion to surfaces and (iii) formation of sessile micro-colonies that secrete extracellular polymeric substance (EPS), leading to bacterial resistance to antibiotics. Antimicrobial peptides (AMPs) are extensively studied with regard to planktonic bacteria but much less so with regard to biofilm formation. In the present study, we investigated how the above three steps are affected by the properties of the AMPs using a series of peptides composed of six lysines and nine leucines, which differ in their sequences and hence their biophysical properties. Treatment with bactericidal peptides at non-inhibitory concentrations resulted in reduced biofilm growth, for some starting from 25 nM which is 0.2 and 0.4% of their minimum inhibitory concentration (MIC 6.3 and 12.5 μM, respectively), continuing in a dose-dependent manner. We suggest that reduced bacterial adhesion to surfaces and decreased biofilm growth are due to the peptide's ability to coat either the biomaterial surface or the bacterium itself. Degradation of established biofilms by bactericidal and non-bactericidal peptides, within 1 h of incubation, occurs by either killing of embedded bacteria or detachment of live ones. In addition to shedding light on the mechanism of biofilm inhibition and degradation, these data may assist in the design of anti-biofilm AMPs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25761937     DOI: 10.1042/BJ20141251

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Evaluation of Peptide-Based Probes toward In Vivo Diagnostic Imaging of Bacterial Biofilm-Associated Infections.

Authors:  Landon W Locke; Kothandaraman Shankaran; Li Gong; Paul Stoodley; Samuel L Vozar; Sara L Cole; Michael F Tweedle; Daniel J Wozniak
Journal:  ACS Infect Dis       Date:  2020-07-14       Impact factor: 5.084

2.  Impairment of Cronobacter sakazakii and Listeria monocytogenes biofilms by cell-free preparations of lactobacilli of goat milk origin.

Authors:  Niharika Singh; Ravinder Kaur; Brij Pal Singh; Namita Rokana; Gunjan Goel; Anil Kumar Puniya; Harsh Panwar
Journal:  Folia Microbiol (Praha)       Date:  2019-06-19       Impact factor: 2.099

3.  Inhibition of Pseudomonas aeruginosa biofilm formation and expression of virulence genes by selective epimerization in the peptide Esculentin-1a(1-21)NH2.

Authors:  Bruno Casciaro; Qiao Lin; Sergii Afonin; Maria Rosa Loffredo; Valeria de Turris; Volker Middel; Anne S Ulrich; YuanPu Peter Di; Maria Luisa Mangoni
Journal:  FEBS J       Date:  2019-06-13       Impact factor: 5.542

Review 4.  Synthetic antibiofilm peptides.

Authors:  César de la Fuente-Núñez; Marlon Henrique Cardoso; Elizabete de Souza Cândido; Octavio Luiz Franco; Robert E W Hancock
Journal:  Biochim Biophys Acta       Date:  2015-12-23

5.  Current Research Approaches to Target Biofilm Infections.

Authors:  Erik van Tilburg Bernardes; Shawn Lewenza; Shauna Reckseidler-Zenteno
Journal:  Postdoc J       Date:  2015-06

6.  Antimicrobial peptides (AMP) in biofilm induced orthopaedic device-related infections.

Authors:  Tristan Hill; Vijay Kumar Jain; Karthikeyan P Iyengar
Journal:  J Clin Orthop Trauma       Date:  2022-01-26

7.  A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.

Authors:  David Pulido; Guillem Prats-Ejarque; Clara Villalba; Marcel Albacar; Juan J González-López; Marc Torrent; Mohammed Moussaoui; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

8.  Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.

Authors:  Ammar Algburi; Yingyue Zhang; Richard Weeks; Nicole Comito; Saskia Zehm; Juanita Pinto; Kathryn E Uhrich; Michael L Chikindas
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

9.  Characterization, modes of action, and application of a novel broad-spectrum bacteriocin BM1300 produced by Lactobacillus crustorum MN047.

Authors:  Yingying Lu; Rakhmanova Aizhan; Hong Yan; Xin Li; Xin Wang; Yanglei Yi; Yuanyuan Shan; Bianfang Liu; Yuan Zhou; Xin Lü
Journal:  Braz J Microbiol       Date:  2020-06-14       Impact factor: 2.476

Review 10.  Gastrointestinal biofilms in health and disease.

Authors:  Jean-Paul Motta; John L Wallace; André G Buret; Céline Deraison; Nathalie Vergnolle
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-28       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.